|
Read more ›› |
By: GlobeNewswire - 02 Mar 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 02 Mar 2024
|
Related companies:
Ultimovacs ASA |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 02 Mar 2024
|
|
|
Read more ›› |
By: PR Newswire Association LLC. - 02 Mar 2024
|
|
|
Read more ›› |
By: PR Newswire Association LLC. - 02 Mar 2024
|
Related companies:
Mezzion Pharmaceuticals, Inc |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 02 Mar 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 02 Mar 2024
|
Related companies:
Zentalis Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 02 Mar 2024
|
Related companies:
Genmab A/S |
|
|
Read more ›› |
By: GlobeNewswire - 02 Mar 2024
|
Related companies:
Adial Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 02 Mar 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 01 Mar 2024
|
|
|
Read more ›› |
By: GlobeNewswire - 01 Mar 2024
|
Related companies:
Cytokinetics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 Mar 2024
|
Related companies:
Lyra Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 Mar 2024
|
Related companies:
NurExone Biologic Ltd. |
|
|
Read more ›› |
By: GlobeNewswire - 01 Mar 2024
|
Related companies:
X4 Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 Mar 2024
|
Related companies:
ClearPoint Neuro, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 Mar 2024
|
Related companies:
BioMea Fusion, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 Mar 2024
|
Related companies:
G1 Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 Mar 2024
|
Related companies:
Oric Pharmaceuticals Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 Mar 2024
|
Related companies:
LeMaitre Vascular, Inc. |
|